✦ LIBER ✦

6549 A phase II study of weekly low-dose docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer

✍ Scribed by Chen, J.S.; Shen, W.C.; Chen, Y.Y.; Huang, J.S.; Yeh, K.Y.; Chen, P.T.; Hsu, H.C.; Lin, Y.C.; Wang, H.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multiple-center phase II study of week

✍ Jen-Shi Chen; Yen-Yang Chen; Jen-Sheng Huang; Kun-Yun Yeh; Ping-Tsung Chen; Wen- 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 181 KB

A randomized phase II study of weekly do

✍ Kim, Young Saing; Sym, Sun Jin; Park, Se Hoon; Park, Inkeun; Hong, Junshik; Ahn, 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 201 KB

A phase II study of capecitabine plus 3-

✍ Park, Y H; Kim, B-S; Ryoo, B-Y; Yang, S H 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

Dose-finding study of weekly docetaxel,

✍ S. H. Waters; A. Gillibrand; H. Berry; S. Kumar; G. Velikova; D. J. Dodwell; Tim 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 223 KB

A phase I/II trial of docetaxel and oxal

✍ Kyoung Ha Kim; Young Suk Park; Myung Hee Chang; Hyo Song Kim; Hyun Jung Jun; Jie 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 274 KB

Risk-adapted, dose escalation study of w

✍ Culine, Stéphane; Terret, Catherine; Cupissol, Didier; Romieu, Gilles; Fabbro, M 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 211 KB